MedTrace Logo

Effect of Bed Bathing Methods on VRE Colonization in ICU Patients

NCT07364435 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 210

Last updated 2026-05-07

Study results available
· View outcomes & findings →

Summary

This randomized controlled trial aims to compare the effects of two different bed bathing methods on vancomycin-resistant Enterococcus (VRE) colonization in adult intensive care unit patients. A total of 210 patients were randomly assigned to receive either daily whole-body bathing with 4% chlorhexidine gluconate solution or daily bed bathing using disposable antibacterial body wipes. VRE colonization was monitored using skin swab cultures collected on days 7, 14, and 21. The results of this study may contribute to infection prevention strategies in intensive care units by identifying effective hygiene practices for reducing VRE colonization.

Conditions

  • Vancomycin-Resistant Enterococcus

Interventions

PROCEDURE

Bed Bath

Daily whole-body bed bathing performed as part of routine ICU care.

DEVICE

Disposable antibacterial bed bath wipes

Daily whole-body bed bathing using disposable antibacterial body cleansing wipes as part of routine ICU care.

DRUG

Chlorhexidine gluconate 4%

A 4% chlorhexidine gluconate solution used during the bed bathing procedure for whole-body skin antisepsis in ICU patients.

Sponsors & Collaborators

  • Özkan Kasap

    lead OTHER_GOV

Principal Investigators

  • Ayfer Ozbas, Prof.Dr. · T.C. DEMIROGLU SCIENCE UNIVERSITY

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-01
Primary Completion
2025-01-01
Completion
2025-08-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07364435 on ClinicalTrials.gov